Inve India ▾

Privi Speciality Chemicals share price & results

Privi Speciality Chemicals Limited· Chemicals· Commodities

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

India's leading manufacturer and exporter of aroma chemicals, serving global fragrance and FMCG majors.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue601 ₹ crore+6.2% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin24.0 %0.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit84.0 ₹ crore+21.7% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity27.83 %+7.8 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin8.97 %+9.8 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)21.62 %+2.1 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

5 of 5 judged targets kept · 11 open · verdicts reflect calls analysed to Q1 FY27.

Privi Speciality Chemicals Limited management guidance track record on Inve: 16 targets tracked across analysed earnings calls (5 achieved, 0 missed, 11 open).

TargetOriginal wordingSaidLatest callVerdict
Production Capacityexpand from 48,000 MT to 54,000 MT by March 2026
Call transcript, Q4 FY25 · 6 May 2025		Q4 FY25Q1 FY27:Timeline for 6,000 MT expansion (to 54k MT) pushed from June 2026 to September 2026.
Call transcript, Q1 FY27 · 31 Jul 2026		Delayed
Revenue & EBITDA TargetRs. 5,000 crores revenue and Rs. 1,000 crore EBITDA in the next 3-5 years
Call transcript, Q1 FY26 · 5 Aug 2025		Q1 FY26Q1 FY27:Vision of Rs. 5,000 crores revenue and Rs. 1,000 crores+ EBITDA in next 3-4 years reiterated.
Call transcript, Q1 FY27 · 31 Jul 2026		On Track
Revenue Growthminimum try to maintain our average growth rate of 20% to 25%
Call transcript, Q4 FY25 · 6 May 2025		Q4 FY25Q4 FY26:FY26 revenue grew 21.73% YoY, meeting the target range.
Call transcript, Q4 FY26 · 12 May 2026		Achieved

Source: Inve Guidance Tracker for Privi Speciality Chemicals Limited · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

11 of Privi Speciality Chemicals Limited's 16 targets are still open. See which are on track and which have gone quiet. The 3 above are the free sample; 13 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹3,356 +3.26% · +₹105.8

Last close 26 Oct 2026 · NSE · INR · Source: Inve

Performance +15.0% 1Y

₹3.0k₹3.5kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 7 Nov 2025Q3 FY26 — 10 Feb 2026Q4 FY26 — 12 May 2026Q1 FY27 — 31 Jul 2026

1Y: ₹2,917.2 on 24 Oct 2025 → ₹3,356. High ₹3,750.8 (2 Jul 2026), low ₹2,616.1 (19 Jan 2026).

Previous close
₹3,250.2
Market cap
₹13.1k Cr
52-week range
₹2,616.1 – ₹3,750.8
One year
+15.86%
Price to earnings (TTM to Jun 2026)
37.45×
Return on equity (TTM to Jun 2026)
27.83%

Overview

Symbol
NSE:PRIVISCL
Sector
Chemicals
Industry
Commodities
Exchange
NSE
Currency
INR

What Privi Speciality Chemicals Limited does

Based on the company's own presentations, annual report and earnings calls.

Privi Speciality Chemicals is India's largest manufacturer and exporter of aroma chemicals, producing pine-based and specialty ingredients used in fragrances, home care, personal care and other consumer applications. It operates two integrated manufacturing plants at Mahad (Maharashtra) and Jhagadia (Gujarat), backward-integrated into processing Crude Sulphate Turpentine (CST) and Gum Turpentine Oil (GTO) sourced from pulp mills and pine sources worldwide. Its 75+ product portfolio is sold to fragrance-and-flavour and FMCG customers across 40+ countries, and includes PRIGIV, a 51:49 joint venture with Swiss fragrance major Givaudan that manufactures specialty molecules exclusively for its JV partner at the Mahad site. Two dedicated R&D centres, at Mahad and Nerul, staffed by a 114-member scientific team, support new-product development and process innovation.

Segments

  • Fragrance
  • Home Care
  • Personal Care
  • Others
Manufacturing plants
2 integrated facilities (Mahad, Maharashtra & Jhagadia, Gujarat)
Installed production capacity
48,000 MTPA
CST processing capacity
36,000 MTPA
GTO processing capacity
12,000 MTPA
Product portfolio
75+ aroma chemical products
R&D centres
2 centres (Mahad & Nerul) with a 114-member R&D team
Founded 1985Headquarters Navi Mumbai, Maharashtra, India Company website

How the price took the results

close before → close after

Q1 FY27
+1.2%
31 Jul
Q4 FY26
−9.0%
12 May
Q3 FY26
−0.5%
10 Feb
Q2 FY26
+3.3%
7 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Privi Speciality Chemicals Limited

Free account: one company. Everything above stays public.

Write why you follow Privi Speciality Chemicals Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Chemicals companies

All Chemicals companies → · Chemicals earnings growth →

Learn to analyse Privi Speciality Chemicals Limited

Guides on how to read this kind of business and the numbers that matter.